NeoGenomics, Inc. opened a NeoGenomics oncology-focused clinical trials testing lab in the same building as the PPD Laboratories central lab in Singapore.    NeoGenomics Chairman and Chief Executive Officer, Doug VanOort noted, “Our customers in the Pharmaceutical Services Division are truly global customers who want the ability to place studies wherever they can find the enrollees. They are looking to partner with laboratories that provide great service and high quality, consistent testing ac...